Article

Connecticut ophthalmologist pleads guilty in health care fraud scheme

Author(s):

Donald Salzberg, MD, conspired with an alleged accomplice at a medical diagnostic company in a scheme that ran for five years, from 2014 through 2019, according to U.S. attorney’s office in Boston.

A Connecticut doctor pleaded guilty today in federal court in Boston to receiving kickbacks in exchange for ordering medically unnecessary brain scans.

According to a news release from the U.S. Attorney’s Office for the District of Massachusetts, Donald Salzberg, MD, 67, of Avon, Conn., pleaded guilty before U.S. Senior District Court Judge Douglas P. Woodlock to one count of conspiracy to commit health care fraud and one count of conspiracy to receive kickbacks.

The court has yet to set a date for a sentencing hearing. Salzberg was charged by an Information on May 23.

Salzberg, who for 36 years has been a licensed ophthalmologist in Connecticut, owned and operated Donald J. Salzberg, MD, an ophthalmology practice in West Hartford, Conn.

According to federal authorities, from 2014 through 2019, Salzberg conspired with a principal for a medical diagnostics company that performed transcranial doppler (TCD) scans – brain scans that measure blood flow in parts of the brain – to order hundreds of medically unnecessary TCD scans in exchange for kickbacks.

Salzberg, whose practice is in West Hartford, Conn., used false patient diagnoses to order the brain scans and the other person would submit claims to Medicare and other insurance companies for payment, prosecutors said.

Salzberg was paid cash kickbacks of $100 to $125 for each test that he ordered, as well as sham administrative services fees. More than $3 million in fraudulent claims were submitted to Medicare and private insurance companies, according to federal authorities.

The U.S. attorney’s office in Boston noted that charge of conspiracy to commit health care fraud provides for a sentence of up to 10 years in prison, three years of supervised release and a fine of up to $250,000. The charge of conspiracy to violate the anti-kickback statute provides for a sentence of up to five years in prison, three years of supervised release and a fine of up to $250,000.

Sentences are imposed by a federal district court judge based upon the U.S. Sentencing Guidelines and statutes which govern the determination of a sentence in a criminal case.

Assistant U.S. Attorneys Rachel Y. Hemani and Howard Locker of Rollins’ Health Care Fraud Unit are prosecuting the case.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.